Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular embolization is a minimally invasive, image-guided procedure that involves the intentional occlusion of a blood vessel by introducing embolic materials (particles, coils, liquid agents, etc.) via a catheter. The goal is to halt blood flow to a diseased area—commonly tumors or sites of bleeding—causing ischemia and subsequent tissue death or control of hemorrhage. It is widely used in interventional radiology, both for the treatment of malignant and benign tumors ("tumor control"), palliative symptom relief, and emergency bleeding control. Embolization can also be used in combination with chemotherapeutic or radioactive agents to enhance local cytotoxic effects. The "target" in this context is the vascular segment supplying the pathological tissue, rather than a molecular entity[7][8][2][5].
Physical occlusion of target vessels using agents (particles, coils, liquids) to block blood flow and induce tissue ischemia/necrosis Delivery of cytotoxic drugs (chemoembolization) or radioactive isotopes (radioembolization), combined with arterial occlusion Chemical destruction of vascular endothelium (ethanol, sclerosing agents)
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular embolization target vessel.